Make your own free website on Tripod.com
Home | 2003 (1997-2003) Cover Shorty | Inside cover | News 11-04 | News 6-04 | Current stock holdings | Election results | Stock from the company | Stock givers /traders | Profit and loss | Balance sheet 2003 | Balance sheet 2000 | RE, S&U, bank stmts 2003 | RE, S&U, bank stmts 2000 | News & history first half 2004 | Dr. Peebles' story | News & history 2001 - 2003 | News & history 1997 - 2000 | Owners like Pfizer strategy | Wal-Mart strategy | Pedi-sales strategy | Celgene takeover of pediatric drugs strategy | Device maker strategy | Your choice for licensing strategies | Ballot | Expenses graph | Expense report 2003 | Goodwill report 2003 | Contacts
Prophy Research Corporation reports
Expense report 2003

Quarter 1 Quarter 2 Quarter 3 Quarter 4 Annual
Patent processing
OptiDose 42 1,084 690 0 1,816 (No Eric since 2001.)
OsteoPat 0 0
Other       0 0
42 1,084 690 0 1,816
Check 1,816
Production
OptiDose 37 0 2 2 41
OsteoPat 0 0
Other       0 0
37 0 2 2 41
Check 41
Library OsteoPat 0 0 0
Office OptiDose 18 67 15 10 110
An report       0 0
18 67 15 10 110
Check 110
Total expenses 97 1,151 707 12 1,967
Check 1,967
Expense Report page 2
Subtotals and Stock Credits
(more accounting gibberish)
Subtotals by project
OptiDose 97 1,151 707 12 1,967
OsteoPat 0 0 0 0 0
Other 0 0 0 0 0
97 1,151 707 12 1967
Stock credits (to stock transactions page, except bank; bank shows on bank statement page)
Bank 25 25 (Bank pd corp fee May 2003.)
Heinz B  BSA 0 0
Eric L  BSA 0 0
0
0
        0
0 25 0 0 25
Ray (diff) 97 1,126 707 12 1,942
Stk cr total 97 1,151 707 12 1,967
check 25
Ray's family tax, HA part
 for spending family $ on these expenses
Ray & Mary each 33.3% $647
Abe & Lucy each 16.7% $324
check $971 $1,942

On to the next page (a "goodwill report", which is the how most of our accounting gets started)